Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.37 |
| ▸ | FPR2 | P25090 | 1/20 | 0.36 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.36 |
| ▸ | OXTR | P30559 | 1/20 | 0.36 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.36 |
| ▸ | GPR183 | P32249 | 1/20 | 0.36 |
| ▸ | KRAS | P01116 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | NAMPT | P43490 | 3/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31108119 | 0.85 | USP30 (0.43) | RORCFPR2USP30KRASNAMPT | |
| SCHEMBL30410253 | 0.85 | ABHD6 (0.42) | RORCGPR119EHMT2OXTRAVPR1A | |
| SCHEMBL30775971 | 0.84 | GPR119 (0.36) | RORCGPR119EHMT2OXTRAVPR1A | |
| SCHEMBL31108104 | 0.84 | FPR2 (0.51) | GPR119FPR2BACE1 | |
| SCHEMBL30775963 | 0.82 | GPR119 (0.36) | RORCGPR119EHMT2OXTRAVPR1A | |
| SCHEMBL31108111 | 0.82 | IDO1 (0.46) | GPR119FPR2USP30 | |
| SCHEMBL3660874 | 0.80 | FEN1 (0.48) | FPR2USP30BACE1 | |
| SCHEMBL29497363 | 0.78 | KRAS (0.36) | RORCGPR119EHMT2OXTRAVPR1A | |
| SCHEMBL26631496 | 0.78 | KRAS (0.36) | RORCGPR119EHMT2OXTRAVPR1A | |
| SCHEMBL25326356 | 0.76 | RORC (0.41) | RORCGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568972-A1 | NEW HETEROCYCLIC COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | disclosed |
| CN-119654326-A | Novel heterocyclic compounds | 豪夫迈·罗氏有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024033277-A1 | NEW HETEROCYCLIC COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-15 | — | — | WO | disclosed |